Is SNN a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

449 people get SNN articles and Market Currents by email alert.

Get email alerts on SNN »

HEADLINES:

Smith & Nephew Management Discusses Q1 2013 Results - Earnings Call Transcript
Thu, May 2
Top 5 Stocks Using GARP And YARP In Search Of Relatively Good Dividend Income Total Return
Richard Shaw • Sun, Apr 28 • 5 Comments
What Will It Take For Stem Cell Companies To Close The Valuation Gap?
Life Sciences Report • Wed, Apr 17 • 1 Comment
Wound Care Market: The Promise Of Healing
Emerging Equities • Sat, Apr 13 • 17 Comments
Acadia Pharmaceuticals Implies Sanuwave Could Triple On New Study Design
Nouvelle Asset Management • Fri, Apr 5 • 4 Comments
Has Smith & Nephew Found Its Next Target?
D. Mero • Thu, Apr 4 • 9 Comments
A Different Take On A Warren Buffett Strategy
Marc Gerstein • Tue, Feb 12 • 28 Comments
Smith & Nephew Management Discusses Q4 2012 Results - Earnings Call Transcript
Thu, Feb 7
Healthpoint Buy To Double Smith & Nephew's U.S. Wound Operations
EP Vantage • Wed, Nov 28, 2012
Smith & Nephew Management Discusses Q3 2012 Results - Earnings Call Transcript
Thu, Nov 1, 2012
Casey Analyst Forecasts Explosive Biotech Growth
Life Sciences Report • Thu, Oct 11, 2012
Zimmer: A Strong Player In The Medical Device Industry
Timothy McIntosh • Wed, Sep 5, 2012 • 6 Comments
4 Low-Debt Healthcare Stocks With Hefty Earnings Trends
ZetaKap • Tue, Sep 4, 2012
Pluristem Therapeutics Shoots From The Hip, Moving Toward The Sports Medicine And Muscle Regeneration Markets
Ray Dirks • Tue, Aug 21, 2012 • 6 Comments
Smith & Nephew Management Discusses Q2 2012 Results - Earnings Call Transcript
Thu, Aug 2, 2012
Johnson & Johnson: Dogged By Uncertainty
Investment Underground • Sun, Jul 8, 2012 • 4 Comments
Smith & Nephew Management Discusses Q1 2012 Results - Earnings Call Transcript
Thu, May 3, 2012
6 High-Dividend-Growth Healthcare Stocks With Low Turnover, Beta, And Payout Ratios
Jeff Paul • Tue, Apr 10, 2012
16 Healthcare Stocks With Impressive Profitability
Kapitall • Tue, Mar 27, 2012 • 1 Comment
March Madness: Final Four Investing Bracket 2012
Matthew Pixa • Mon, Mar 19, 2012 • 13 Comments

To learn more about Seeking Alpha Pro, click here.

Has Smith & Nephew Found Its Next Target?
D. Mero • Thu, Apr 4 • 9 Comments
Healthpoint Buy To Double Smith & Nephew's U.S. Wound Operations
EP Vantage • Wed, Nov 28, 2012
Why Smith & Nephew Is an Attractive Takeover Target
Investment U • Mon, Jan 24, 2011
Smith & Nephew Opens Beijing Facility to Boost Production for International Customers
ChinaBio Today • Thu, May 27, 2010 • 1 Comment
Smith & Nephew Shifts Focus to China Operations
ChinaBio Today • Sat, Aug 23, 2008
Smith & Nephew To Market "Spine Fix" Bone Cement
Sara Calabro • Thu, May 17, 2007
Smith & Nephew: Deal With Teknimed Inks Has Healthy Potential
Sara Calabro • Wed, May 16, 2007
Smith & Nephew Buys BlueSky To Penetrate Wound Care Market
Sara Calabro • Mon, May 14, 2007

Top 5 Stocks Using GARP And YARP In Search Of Relatively Good Dividend Income Total Return
Richard Shaw • Sun, Apr 28 • 5 Comments
What Will It Take For Stem Cell Companies To Close The Valuation Gap?
Life Sciences Report • Wed, Apr 17 • 1 Comment
Wound Care Market: The Promise Of Healing
Emerging Equities • Sat, Apr 13 • 17 Comments
Acadia Pharmaceuticals Implies Sanuwave Could Triple On New Study Design
Nouvelle Asset Management • Fri, Apr 5 • 4 Comments
A Different Take On A Warren Buffett Strategy
Marc Gerstein • Tue, Feb 12 • 28 Comments
Casey Analyst Forecasts Explosive Biotech Growth
Life Sciences Report • Thu, Oct 11, 2012
Zimmer: A Strong Player In The Medical Device Industry
Timothy McIntosh • Wed, Sep 5, 2012 • 6 Comments
4 Low-Debt Healthcare Stocks With Hefty Earnings Trends
ZetaKap • Tue, Sep 4, 2012
Pluristem Therapeutics Shoots From The Hip, Moving Toward The Sports Medicine And Muscle Regeneration Markets
Ray Dirks • Tue, Aug 21, 2012 • 6 Comments
Johnson & Johnson: Dogged By Uncertainty
Investment Underground • Sun, Jul 8, 2012 • 4 Comments
6 High-Dividend-Growth Healthcare Stocks With Low Turnover, Beta, And Payout Ratios
Jeff Paul • Tue, Apr 10, 2012
16 Healthcare Stocks With Impressive Profitability
Kapitall • Tue, Mar 27, 2012 • 1 Comment
March Madness: Final Four Investing Bracket 2012
Matthew Pixa • Mon, Mar 19, 2012 • 13 Comments
5 Solid Healthcare Stocks To Profit From
ValueMax • Tue, Feb 21, 2012
9 European Stocks With Impressive Profitability
Kapitall • Thu, Jan 26, 2012
Stryker Preparing For A Hard Slog In 2012
Stephen Simpson • Wed, Jan 25, 2012 • 9 Comments
5 Dividend Stocks Plus 9 Core ETFs Form Diversified Portfolio
Lowell Herr • Fri, Jan 13, 2012 • 8 Comments
10 Healthcare Stocks With Consistently Rising Gross Profits
Kapitall • Wed, Dec 21, 2011
15 Healthcare Stocks With Impressive Profitability
Kapitall • Thu, Dec 15, 2011 • 1 Comment
Sanuwave Q3 Results In Line; Shares Still Cheap
Brian Marckx • Mon, Nov 14, 2011 • 1 Comment

Smith & Nephew Management Discusses Q1 2013 Results - Earnings Call Transcript
Thu, May 2
Smith & Nephew Management Discusses Q4 2012 Results - Earnings Call Transcript
Thu, Feb 7
Smith & Nephew Management Discusses Q3 2012 Results - Earnings Call Transcript
Thu, Nov 1, 2012
Smith & Nephew Management Discusses Q2 2012 Results - Earnings Call Transcript
Thu, Aug 2, 2012
Smith & Nephew Management Discusses Q1 2012 Results - Earnings Call Transcript
Thu, May 3, 2012
Smith & Nephew plc Management Discusses Q4 2011 Results - Earnings Call Transcript
Thu, Feb 2, 2012
Smith & Nephew plc Management Discusses Q3 2011 Results - Earnings Call Transcript
Fri, Nov 4, 2011
Smith & Nephew plc Management Discusses Q2 2011 Results - Earnings Call Transcript
Fri, Aug 5, 2011
Smith & Nephew CEO Discusses Q4 2010 Results - Earnings Call Transcript
Thu, Feb 10, 2011
Smith & Nephew plc Q2 2010 Earnings Call Transcript
Sat, Aug 7, 2010
Smith & Nephew PLC Q3 2007 Earnings Call Transcript
Sun, Nov 4, 2007

London Markets: Vodafone helps lift U.K. stocks in choppy action

at MarketWatch.com (Nov 28, 2012)
London Markets: U.K. stocks drop after ECB disappointment

at MarketWatch.com (Aug 2, 2012)
London Markets: FTSE 100 pares gains after U.S. data, miners weigh

at MarketWatch.com (May 3, 2012)
Europe Markets: Europe stocks trim gains after Draghi, U.S. data

at MarketWatch.com (May 3, 2012)
London Markets: London market slides; ITV shares gain

at MarketWatch.com (Nov 14, 2011)
CFOs make case for international tax reform

at MarketWatch.com (May 12, 2011)
Synthes shares rally after it confirms J&J talks

at MarketWatch.com (Apr 18, 2011)
Indications: U.S. stock futures drop; Citigroup beats

at MarketWatch.com (Apr 18, 2011)
London Markets: IAG, Diageo lead FTSE index to losses

at MarketWatch.com (Feb 10, 2011)
European Stocks to Watch: Smith & Nephew offers buyer growth, cost savings

at MarketWatch.com (Jan 25, 2011)
Web Extra Pops & Drops: St. Joe, Dangdang...

at CNBC.com (Jan 18, 2011)
London Markets: Miners drag London to lower close

at MarketWatch.com (Jan 14, 2011)
Movers & Shakers: Monday’s biggest gaining and declining stocks

at MarketWatch.com (Jan 10, 2011)
Stocks End Mixed Ahead of Earnings; Tech Up

at CNBC.com (Jan 10, 2011)
Stocks Mixed Before Close; Travelers Gains

at CNBC.com (Jan 10, 2011)
Stocks Weaken Despite M&A; Energy Slips

at CNBC.com (Jan 10, 2011)
London Markets: London stocks drop; Smith & Nephew soars

at MarketWatch.com (Jan 10, 2011)
Europe Markets: European stocks slump on debt fears

at MarketWatch.com (Jan 10, 2011)
Earnings Watch: Updates, advisories and surprises

at MarketWatch.com (Nov 5, 2010)
London Markets: Unilever underperforms as FTSE slips

at MarketWatch.com (Aug 5, 2010)

SNN vs. ETF Alternatives

Company Description

Currently, there's no company description for SNN.

Sector: Healthcare

Industry: Medical Appliances & Equipment

Country: United Kingdom

All
| Earnings
| Dividends
| M&A
| On the move

Thursday, February 7, 5:02 AM Smith & Nephew (SNN): Q4 EPS of 21.6 cent beats by 0.5 cents. Revenues of $1.11B (-2.7% Y/Y) beat by $10M. Declares final dividend of 16.2 cents/share, bringing the total for 2012 to 26.1 cents/share. Shares +0.35% in London. (PR) Comment! [Earnings, Healthcare]
Thursday, January 17, 7:44 PM The FDA is concerned whether several medical devices already on the market, such as electroconvulsive therapy devices for depression and emergency defibrillators, require additional evidence to prove they're safe. It's issued a safety advisory, saying patients with symptoms suggesting their devices aren't functioning properly should be considered for testing of possible metal ions in their bloodstream. Symptoms include: skin rashes, neurological changes such as hearing and vision impairment, and psychological status changes including depression. Comment! [Healthcare]
Wednesday, November 28, 2012, 8:07 AM Smith & Nephew (SNN) agrees to acquire Healthpoint Biotherapeutics for $782M, allowing the British medical products manufacturer to expand into the wound therapy sector. SNN expects the acquisition to exceed its cost of capital in the third full year following acquisition, to be broadly EPSA neutral in 2013 and accretive thereafter. Comment! [Healthcare, M&A]
Friday, June 1, 2012, 10:54 AM U.K. medical device maker Smith & Nephew (SNN -3.2%) slips after saying it's withdrawing the optional metal liner component used in its hip implants, saying it isn't satisfied with clinical results. Approximately 7,700 metal liners have been implanted since the component was introduced in 2007, the majority of which have been used in stemmed total hip replacements. Comment! [Healthcare, Global & FX, On the Move]
Thursday, May 3, 2012, 3:27 AM Smith & Nephew (SNN): Q1 trading profit of $252M vs. $241M in the year-earlier period. Excluding restructuring and acquisition costs, EPS of $0.195/share, in-line. Knee replacements and wound care helped drive the profit growth. Revenue rose to $1.08B from $1.06B, in-line with estimates. Comment! [Healthcare, Earnings]
Monday, February 6, 2012, 12:02 PM The SEC slaps a $22M fine on Smith & Nephew (SNN +0.2%) for allegedly violating the Foreign Corrupt Practices Act with bribes paid to Greek doctors to win business. The complaint filed in federal court (.pdf) says that the company kept a slush fund to make the payments. Comment! [Healthcare]
Wednesday, January 4, 2012, 2:48 AM Smith & Nephew (SNN) will spin off its biologics business into a new joint venture that will be majority owned by healthcare investor Essex Woodlands. Smith & Nephew will receive ~$98M in exchange, which will be used to pay down debt, and a $160M five-year note from the new JV. Comment! [M&A, Healthcare]
Thursday, March 17, 2011, 9:10 AM Premarket gainers: CTIC +11%. SNE +8%. CIGX +7%. KYO +6%. SI +6%. GPL +5%. CPST +5%. FDX +5%. PC +5%. STD +5%. RDS +4%. VOD +4%. RIO +4%. TEF +4%. ARMH +4%. CREE +4%. SNN +4%. TOT +4%. ABB +4%. BBVA +4%. VE +4%. MT +4%. UPS +4%. NOK +3%. ALU +4%. HERO +3%. URRE +3%. CLF +3%. LVLT +3%. BHP +3%. STO +3%. MGM +3%.
Losers: GMR -30%. GES -7%. KWK -6%. HSOL -6%. NRP -6%. SNBC -5%. LULU -4%. PHI -4%. THQI -3%. Comment!
Wednesday, February 2, 2011, 2:50 PM Smith & Nephew (SNN +1.1%), Europe's largest maker of knee and hip replacement products, gained 16% when speculation began that Johnson & Johnson (JNJ +0.2%) was looking at a potential takeover of the company. Bloomberg calculates that it's still worth an additional 60%, or $15.6B, in an acquisition. 1 Comment
Tuesday, January 18, 2011, 9:00 AM Premarket gainers: ARIA +33%. SBIB +19%. HEV +10%. CXDC +9%. VOD +5%. TGB +4%. ERJ +4%. ASTM +4%. SNN +4%.
Losers: CMA -6%. AAPL -5%. AVGO -5%. C -5%. WLOCD -4%. GSK -4%. Comment!
Sunday, January 16, 2011, 12:56 PM J&J (JNJ) is reportedly considering a new takeover approach for Smith & Nephew (SNN), which denies it's in deal talks. The Sunday Times says a bid would be worth at least 800 pence, valuing the company at more than £7B ($11B), up from a 750p/share bid reportedly rejected last year. Comment!
Friday, January 14, 2011, 8:13 AM Smith & Nephew (SNN) says it is not involved in talks that could result in a merger or a takeover of the company. Previous reports had discussed interest from Johnson & Johnson (JNJ), and a new report said talks had begun with Biomet about a possible merger. Shares -1.1% in London trading. Comment!
Monday, January 10, 2011, 9:00 AM Premarket gainers: PLA +17%. CNXT +16%. SNN +12%. LDK +9%. RAS +6%. ACW +5%. LXRX +5%. SPWRA +5%. XING +5%. INHX +5%. AVL +4%. SLE +4%. SHZ +4%. REE +4%. SOL +4%.
Losers: STRA -26%. APOL -9%. COCO -8%. CTIC -6%. ROVI -5%. FCEL -5%. IDX -4%. AIB -4%. Comment!
Monday, January 10, 2011, 7:50 AM Smith & Nephew (SNN) is getting a nice premarket boost after weekend reports that J&J (JNJ) made a £7B ($11B) takeover offer for the British medical equipment firm late last year, and is now considering a higher bid. SNN +11.75%. Comment!
Sunday, January 9, 2011, 9:17 AM British medical equipment firm Smith & Nephew (SNN) reportedly rejected a £7B ($11B) takeover approach by Johnson & Johnson (JNJ) late last year, with J&J now considering whether to make a higher bid. Comment!
Wednesday, December 8, 2010, 9:00 AM Premarket gainers: OREX +128%. VVUS +21%. NVIS +21%. ARNA +16%. FBP +10%. AIB +9%. IRE +8%. SNN +5%. DDMX +4%. RTK +4%.
Losers: PUDA -10%. SWC -6%. KFN -6%. JBLU -5%. MNTA -5%. GST -5%. GDOT -5%. Comment!

Dividend Sheet
$PFLT $KED and $MAIN are tomorrow's top yielding ex-dividend stocks - http://stks.co/gRgB - 18 Shares - 4.18% Yield $FL $VALE $CMTL $SNN
Apr 16, 4:25 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

joe senior
$SNN I was looking at the year end information SNN just put out. Can anyone tell me the worth of this on a per-share basis?
Feb 21, 9:31 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
4 Low-Debt Healthcare Stocks With Hefty Earnings Trends http://bit.ly/Tjjpsm $MD $SCLN $SNN $YDNT @ZetaKap
9/4/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Dividend Sheet
Big Players: Long-Term Financial Analysis of Johnson & Johnson ++ http://t.co/9hijxHA ++ $MDT $ZMH $SNN
5/14/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Dividend Sheet
19 Healthcare Growth Stocks With 20+ Percent Operating Margins + http://t.co/dEKtgkk + $BCR $LNCR $LLY $JNJ $ATRI $BDX $SNN $YDNT $NVS $AZN
3/6/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Hillbilly Stock Star
DEJ......wildcatter catches a bid, hopefully they do a deal like SNN, both wildcat longs.
3/4/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Dr. Kris
M&A rumor: Bloomberg reporting US pvt eqty firm poised to offer $63/share SNN following positive rec's from GS analysts. Stock up 7% to $52
12/8/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Andrew Shapiro
$SPA Just posted on Sparton's Delphi Medical acquisition at my instablog $NUVA $SI $JNJ $SNN $FLEX, $JBL $SLR, $DPHIQ.PK, $GM, $MTLQQ.pk
9/6/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Andrew Shapiro
$SPA Just posted a detailed analysis of Sparton's Delphi Medical acquisition on my instablog at http://seekingalpha.com/p/1yxa $NUVA $SI $JNJ $SNN
9/6/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

SNN Smith & Nephew plc

SNN

Smith & Nephew plc